TAACR Award for Lifetime Achievement in Cancer Research
Steven A. Rosenberg will be presented with the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research at the AACR Annual Meeting 2022, to be held in New Orleans April 8-13.
The American Association for Cancer Research has elected 33 scientists to its 2022 class of Fellows of the AACR Academy.
On March 2, a bus filled with Ukrainian children was getting ready to leave Odesa for the border of Moldova, Ukraine’s closest neighbor.
The American Association for Cancer Research released the AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care, providing a comprehensive view of the burden of COVID-19 among patients with cancer; the challenges presented by the pandemic in cancer research and patient care; and the changes implemented during the pandemic that have unexpectedly improved research practices and access to care.
Congress needs to increase the FY22 base budgets of NIH and NCI by $3.2 billion and $1.1 billion, respectively, over FY21 levels, the American Association for Cancer Research said in its 2021 Cancer Progress Report.
In an expression of support for increasing funding for cancer research and prevention, the Bidens earlier this week endorsed the National Cancer Research Month.
NCI needs more funding to increase its low success rate of NCI-funded grant applications, David A. Tuveson said in testimony before the House Committee on Appropriations.
In surveys, as many as 15% of Americans say that they will not get a COVID-19 vaccine under any circumstances, and another 17% are in the “wait-and-see” category, holding out to observe how others fare.If these numbers are correct, the U.S. has almost no wiggle room as it strives to reach herd immunity to COVID-19.
President Joe Biden’s proposed Advanced Research Projects Agency-Health would be a welcome partner to NCI—particularly in conducting large, collaborative clinical investigations, NCI Director Ned Sharpless said.“I think having ARPA-H as part of the NIH is good for the NCI,” Sharpless said April 11 in his remarks at the annual meeting of the American Association for Cancer Research. “How this would fit with the ongoing efforts in cancer at the NCI is still something to work out.”